A&M Global Transaction Advisory Group Managing Director Bob Ruckh was recognized by the Financial Accounting Standards Board (FASB) for his appointment to its Small Business Advisory Committee (SBAC), in a recent press release.
"The SBAC serves as a standing resource for the FASB. Its role is to provide focused input and feedback from a small public company perspective, consider whether there are differences in perspectives for small public versus private companies, and assist the FASB and its staff on matters for which the FASB may seek guidance." Richard R. Jones, Chair, Financial Accounting Standards Board (FASB).
“Bob is one of the world’s leading transaction executives, full stop – and his 40+ years of PE experience will bring a valuable perspective to FASB’s Small Business Advisory Committee. His deep knowledge is paired with unique guidance, and he will bring immediate impact to the committee. Congratulations to Bob, and applause to the FASB, on this very deserved appointment.” Paul Aversano, Managing Director, Global Practice Leader for Global Transaction Advisory Group.
Click to read the announcement
Infrastructure Pulse Survey Report: Spring 2026, North America and Europe
May 14, 2026
The Infrastructure Pulse Survey Report for Spring 2026, published by Alvarez & Marsal in collaboration with the Global Infrastructure Investor Association (GIIA), offers an insight into how investors across North America and Europe are reading the current investment landscape through a period of macroeconomic and geopolitical uncertainty.
Alvarez & Marsal Continues to Strengthen Transaction Advisory Practice in Australia with Senior Talent
May 13, 2026
Alvarez & Marsal (A&M), a leading global professional services firm, today announced the appointment of Sydney-based Roshan Emmanuel as a Managing Director within its Global Transaction Advisory Group (Global TAG), underscoring the firm’s rapid growth and continued investment in the Australian market.
Carving Out Success: Life Sciences Companies Are Rationalizing Portfolios by Divesting Non-Core Assets
May 12, 2026
Historically, large healthcare and life sciences corporations have focused deal activity on a breadth of diverse assets. However, the landscape is undergoing significant transformation as businesses shift to rationalize their portfolios and invest in fewer core areas.
Alvarez & Marsal’s Global Transaction Advisory Group Continues to Expand Senior Talent Ranks in Europe
May 6, 2026
The practice welcomes new Managing Directors Tobias Ranker and Eric Poitevin to support growth in Germany and France
